EVALUATING THE EFFECTIVENESS OF PROPHYLACTIC REPLACEMENT THERAPY IN CHILDREN WITH HEMOPHILIC ARTHROPATHY IN DYNAMICS ON MAGNETIC RESONANCE IMAGING
https://doi.org/10.15690/pf.v12i2/1275
Abstract
Modifications in treatment guidelines of hemophilic arthropathy changed the role of diagnostic X-ray imaging methods. Diagnostic methods are used both for determination of the degree of joint destruction and long-term evaluation of the joint conditions and therapy adequacy and effectiveness. Aim. Magnetic resonance imaging (MRI) dynamics for joint condition assessment in children with hemophilic arthropathy receiving prophylactic factor replacement therapy concentrated rolling VIII. Materials and methods. We studied 13 boys aged 5 to 14 years (mean age 8.9 years) with hemophilia type A severe form of the disease (factor VIII deficiency <1%) at the baseline. The average age of appearance of hemarthrosis is 2.1 years (from 1.8 to 2.9 years). The frequency of bleeding into the joints of patients older than 1 year was 2-3 times per year. Magnetic resonance imaging (ToshibaExcelArtVantage, 1,5 T) was performed in 13 patients, 35 joints were examined, 57 studies were executed. Control study of joints was conducted in 1, 2 or 3 years depending on the frequency of hemarthrosis during the year and the severity of joint damage primarily identified. Results. The results included both the improvement along with the stabilization of intra-state structures and the negative dynamic shifts. MRI showed that the reduction of bleeding in the joints on the background of hemostatic replacement therapy led to subsiding inflammation in the joints and significant decrease in the amount of intra-articular effusion (n = 11; p = 0.03), decrease in the number of joints with symptoms of bone marrow edema (n = 8), the absence of observations with negative changes in the form of increasing the thickness of the synovial membrane. Negative dynamics of joint condition presented as increasing of the depth and length of erosive process (n = 5; 22.7%), degenerative changes in ligaments and menisci (n = 2; 9%) under the condition of regular administration of clotting factors was associated with the development of the inhibitory form of the disease which was confirmed by laboratory data. Conclusions. Magnetic resonance imaging evaluates the effectiveness of replacement therapy in children with hemophilia.
About the Authors
I. S. RemzantsevaRussian Federation
V. D. Zavadovskaya
Russian Federation
L. M. Ogorodova
Russian Federation
Z. A. Maevskaya
Russian Federation
O. Yu. Kilina
Russian Federation
A. N. Kailina
Russian Federation
CONFLICT OF INTEREST
The authors have indicated they have no financial relationships relevant to this article to disclose.
References
1. Andreev Yu.N. Mnogolikaya gemofiliya [The Many Faces of Hemophilia]. Moscow, N'yudiamed, 2006. 232 p.
2. Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. Journal of Blood Medicine. 2014; 5: 207−218.
3. Monahan P.E., Doria A.S., Ljung R., Jiménez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments. Haemophilia. 2012 Jul; 18 (Suppl. 5): 17−26.
4. Valentino L.A. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia. 2009 May; 15 (3): 733−42.
5. Acharya S.S. Hemophilic joint disease ― current perspective and potential future strategies. Transfus Apher Sci. 2008 Feb; 38 (1): 49−55.
6. Tret'yakova O.S. Hemophilia in children: current approaches to treatment and prevention. Dityachii Likar = Pediatrician. 2012; 6: 26−32.
7. Rodriguez-Merchan E.C., Jimenez-Yuste V., Aznar J.A., Hedner U., Knobe K., Lee C.A., Ljung R., Querol F., Santagostino E., Valentino L.A., Caffarini A. Joint protection in haemophilia. Haemophilia. 2011 Sep; 17 (Suppl. 2): 1−23.
8. Franchini M., Mannucc M. Past, present and future of hemophilia: a narrative review. Orphanet J of Rare Dis. 2012; 7: 24.
9. Bryukhanov A.V., Vasil'ev A.Yu. Magnitno-rezonansnaya tomografiya v diagnostike zabolevanii sustavov [Magnetic resonance imaging in the diagnosis of diseases of the joints]. Barnaul, Altaiskii poligraficheskii kombinat, 2001. 198 p.
10. Pergantou H., Platokouki H., Matsinos G., Papakonstantinou O., Papadopoulos A., Xafaki P., Petratos D., Aronis S. Assessment of the progression of haemophilicarthropathy in children. Haemophilia. 2010 Jan; 16 (1): 124−9.
11. Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516−24.
12. Oymak Y., Yildirim A.T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R.C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157−159.
Review
For citations:
Remzantseva I.S., Zavadovskaya V.D., Ogorodova L.M., Maevskaya Z.A., Kilina O.Yu., Kailina A.N. EVALUATING THE EFFECTIVENESS OF PROPHYLACTIC REPLACEMENT THERAPY IN CHILDREN WITH HEMOPHILIC ARTHROPATHY IN DYNAMICS ON MAGNETIC RESONANCE IMAGING. Pediatric pharmacology. 2015;12(2):137-142. (In Russ.) https://doi.org/10.15690/pf.v12i2/1275